ADC Therapeutics

Biotech

New year, new C-suite execs—Chutes & Ladders

The biopharma world rang in the new year with new faces and C-suite exits at Moderna, Biogen, Galapagos, Zymeworks and more
Gabrielle Masson , Max Bayer Jan 6, 2023 9:30am

ADC therapy sidelined after FDA nixes accelerated review chance

Nov 8, 2022 10:25am

Rubius execs depart as the walls close in—Chutes & Ladders

Nov 4, 2022 9:30am

Pheon hauls in $68M series A off the excitement of budding ADCs

Sep 28, 2022 3:00am

Biotech's 2022 gender diversity track record—Chutes & Ladders

Jun 17, 2022 9:30am

ADC Therapeutics scores high response for Hodgkin lymphoma drug

Jun 10, 2022 11:27am